Successful treatment of a patient with herbal drug-induced immune thrombocytopenic purpura using freshly donated blood

Main Article Content

Marcellinus Uchechukwu Nwagu


Drug-induced thrombocytopenia (DITP), which also includes thrombocytopenia induced by beverages, foods, and herbal remedies, is an important clinical problem for haematologists. Drug-induced thrombocytopenia is often misdiagnosed as immune thrombocytopenic purpura with resulting inappropriate treatment. Immune thrombocytopenic purpura (ITP) is a clinical disorder that leads to easy bruising (purpura), excessive bleeding or extravasation of blood from capillaries into skin and mucous membranes (petechiae). The bleeding tendency is due to decreased number of circulating platelets (thrombocytopenia). There is production of antibodies against the platelets by the patient’s immune system. This case report was conducted to introduce the effectiveness of freshly donated blood and steroids on patients with immune thrombocytopenic purpura (ITP) after ingestion of herbal drugs.

Case description
DT was a 30-year old female who presented with bleeding per vagina, gum bleeding and weakness. The patient did not have any systemic disease that would cause any spontaneous hemorrhage. The patient was referred to a hematologist urgently and her thrombocyte count was found to be 2000/ìL. Other test results were in normal range. Full blood count revealed severe thrombocytopenia. Freshly donated whole blood was given to the patient and then the changes in her general condition were analyzed, as well as the blood test results.

In the absence of platelet concentrate especially in rural settings and resource-poor countries, freshly donated whole blood can be used in the management of a case of severe thrombocytopenia from ITP.

Article Details

How to Cite
Nwagu, M. U. (2018). Successful treatment of a patient with herbal drug-induced immune thrombocytopenic purpura using freshly donated blood. Universa Medicina, 37(3), 222–226.
Case Report


Stasi R. Pathophysiology and therapeutic options in primary immune thrombocytopenia. Blood Transfus 2011;9:262–73. doi: 10.2450/2010.0080-10.

Rodeghiero F, Stasi R, Gernsheimer T, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 2009;11:2386–93. doi: 10.1182/blood-2008-07-162503.

McMillan R. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production. Hematol Oncol Clin North Am 2009;23:1163–75. doi: 10.1016/j.hoc.2009.08.008.

Schwartz RS. Immune thrombocytopenic purpura—from agony to agonist. N. Engl J Med 2007;357:2299–301. doi: 10.1056/NEJMe0707126.

Siegal D, Crowther M, Cuker A. Thrombopoietin receptor agonists in primary ITP. Semin Hematol 2013;50:S18–21. doi: 10.1053/j.seminhematol.2013. 03.005.

Stasi R, Cooper N, Del Poeta G. Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell-depleting therapy with rituximab. Blood 2008;112:1147–50. doi: 10.1182/blood-2007-12-129262.

Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood 2017;129:2829-35. doi: 10.1182/blood-2017-03-754119.

Ghanima W, Godeau B, Cines DG, et al. How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. Blood 2012;120:960-9. doi: 10.1182/blood-2011-12-309153.

Kayal L, Jayachandran S, Singh K. Idiopathic thrombocytopenic purpure. Contemp Clin Dent 2014;5:410–4. doi: 10.4103/0976-237X.137976.

Gernsheimer T. Chronic idiopathic thrombocytopenic purpura: mechanisms of pathogenesis. Oncologist 2009;14:12–21. doi: 10.1634/theoncologist.2008-0132.

Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013;9:30. doi: 10.1186/1710-1492-9-30.

Van der Heijden R, Jacobs DI, Snoeijer W, et al. The Catharanthus alkaloids: pharmacognosy and biotechnology. Curr Med Chem 2004;11:607–28.

Enrique R. Vinca alkaloids. The evolution of drug discovery: from traditional medicines to modern drugs. New York: John Wiley & Sons; 2011.

Cooper R, Deakin JJ. Botanical miracles: chemistry of plants that changed the world. San Francisco, California: CRC Press LLC;2016;46–51.

Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016;7:87-97. doi: 10.5306/wjco.v7.i1.87.

Keglevich P, Hazai L, Gyorgy K, et al. Modifications on the basic skeletons of vinblastine and vincristine. Molecules 2012;17:5893–914. doi: 10.3390/molecules17055 893.

Stasi R, Sarpatwari A, Segal JB, et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009;113:1231–40. doi: 10.1182/blood-2008-07-167155.

Hassan A, Adebayo A, Musa AU, et al. Clinical feature and management of immune thrombocytopenic purpura in a tertiary hospital in Northwest Nigeria. Niger Med J 2017;58:68–71. doi: 10.4103/0300-1652.219343.

Fakeye TO, Adisa R, Musa IE. Attitude and use of herbal medicines among pregnant women in Nigeria. BMC Complement Altern Med 2009;9:53. doi: 10.1186/1472-6882-9-53.

Adinya IB, Akpet SO, Lawrence IE, et al. Use of native herbs in health management in Nigeria. Afr J Livestock Ext 2012;10:6-14.

Oreagba IA, Oshikoya KA, Amachree M. Herbal medicine use among urban residents in Lagos, Nigeria. BMC Complement Altern Med 2011;11: 117-22. doi: 10.1186/1472-6882-11-117.